nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—Ceramide signaling pathway—ASAH1—intracranial aneurysm	0.0718	0.0783	CbGpPWpGaD
Ingenol Mebutate—PRKCD—IL-6 signaling pathway—TIMP1—intracranial aneurysm	0.0363	0.0396	CbGpPWpGaD
Ingenol Mebutate—PRKCD—IL6-mediated signaling events—TIMP1—intracranial aneurysm	0.0338	0.0369	CbGpPWpGaD
Ingenol Mebutate—PRKCA—artery—intracranial aneurysm	0.0301	0.361	CbGeAlD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.028	0.0305	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Endothelins—EDNRA—intracranial aneurysm	0.0274	0.0299	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Endothelin Pathways—EDNRA—intracranial aneurysm	0.0264	0.0288	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Syndecan-2-mediated signaling events—MMP2—intracranial aneurysm	0.0201	0.022	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.019	0.0207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—AGER—intracranial aneurysm	0.0182	0.0198	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—NCF1—intracranial aneurysm	0.018	0.0196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Syndecan-4-mediated signaling events—MMP9—intracranial aneurysm	0.0166	0.0181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—PAR1-mediated thrombin signaling events—NOS3—intracranial aneurysm	0.0164	0.0178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.0161	0.0175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Endothelins—EDNRA—intracranial aneurysm	0.0158	0.0172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—NCF1—intracranial aneurysm	0.015	0.0164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.0148	0.0161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Thromboxane A2 receptor signaling—NOS3—intracranial aneurysm	0.0132	0.0144	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.0132	0.0144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFR1 specific signals—NOS3—intracranial aneurysm	0.0129	0.014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—brainstem—intracranial aneurysm	0.0128	0.154	CbGeAlD
Ingenol Mebutate—PRKCD—LPA receptor mediated events—MMP2—intracranial aneurysm	0.0127	0.0139	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.0124	0.0135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.0121	0.0132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Endothelin Pathways—NOS3—intracranial aneurysm	0.0116	0.0127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.0116	0.0127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.0115	0.0125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—cerebellum—intracranial aneurysm	0.0115	0.138	CbGeAlD
Ingenol Mebutate—PRKCD—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.0113	0.0124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.0109	0.0119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—ELN—intracranial aneurysm	0.0105	0.0115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—AGER—intracranial aneurysm	0.0104	0.0114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—NCF1—intracranial aneurysm	0.0103	0.0112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.0103	0.0112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.0098	0.0107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—LPA receptor mediated events—MMP9—intracranial aneurysm	0.00955	0.0104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Syndecan-4-mediated signaling events—MMP9—intracranial aneurysm	0.00955	0.0104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PAR1-mediated thrombin signaling events—NOS3—intracranial aneurysm	0.00939	0.0102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00931	0.0102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—brain—intracranial aneurysm	0.00931	0.112	CbGeAlD
Ingenol Mebutate—PRKCD—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.0089	0.00971	CbGpPWpGaD
Ingenol Mebutate—PRKCA—midbrain—intracranial aneurysm	0.00817	0.0981	CbGeAlD
Ingenol Mebutate—PRKCD—Signaling Pathways—STARD13—intracranial aneurysm	0.00805	0.00879	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SLC25A16—intracranial aneurysm	0.00797	0.0087	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.0079	0.00862	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00789	0.0086	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.00779	0.00849	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Thromboxane A2 receptor signaling—NOS3—intracranial aneurysm	0.0076	0.0083	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.00757	0.00826	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—NOS3—intracranial aneurysm	0.00745	0.00812	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00712	0.00776	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CTSS—intracranial aneurysm	0.007	0.00763	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00667	0.00727	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CTSS—intracranial aneurysm	0.00652	0.00711	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.00651	0.0071	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CTSK—intracranial aneurysm	0.00644	0.00703	CbGpPWpGaD
Ingenol Mebutate—PRKCA—cerebellum—intracranial aneurysm	0.00632	0.0759	CbGeAlD
Ingenol Mebutate—PRKCD—Innate Immune System—CTSK—intracranial aneurysm	0.006	0.00654	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.0059	0.00644	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.00586	0.0064	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.00566	0.00617	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00563	0.00614	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—RBBP8—intracranial aneurysm	0.0056	0.00611	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00535	0.00584	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00533	0.00582	CbGpPWpGaD
Ingenol Mebutate—PRKCA—brain—intracranial aneurysm	0.00513	0.0616	CbGeAlD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00511	0.00558	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TIMP1—intracranial aneurysm	0.00505	0.00551	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CTSB—intracranial aneurysm	0.00497	0.00542	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.00488	0.00532	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CCL2—intracranial aneurysm	0.0047	0.00513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STARD13—intracranial aneurysm	0.00463	0.00505	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SLC25A16—intracranial aneurysm	0.00458	0.00499	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00453	0.00494	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—NOS3—intracranial aneurysm	0.00428	0.00466	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC25A16—intracranial aneurysm	0.00383	0.00418	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTSS—intracranial aneurysm	0.0038	0.00414	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTSS—intracranial aneurysm	0.00374	0.00408	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTSK—intracranial aneurysm	0.00349	0.00381	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTSK—intracranial aneurysm	0.00345	0.00376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.00337	0.00367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00336	0.00367	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00327	0.00357	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.00325	0.00355	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AGER—intracranial aneurysm	0.00321	0.0035	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CST3—intracranial aneurysm	0.00305	0.00333	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00297	0.00324	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.00291	0.00318	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TIMP1—intracranial aneurysm	0.0029	0.00316	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTSB—intracranial aneurysm	0.00289	0.00315	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NCF1—intracranial aneurysm	0.00288	0.00314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTSB—intracranial aneurysm	0.00285	0.00311	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NCF1—intracranial aneurysm	0.00266	0.0029	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ASAH1—intracranial aneurysm	0.00254	0.00277	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP2—intracranial aneurysm	0.00235	0.00256	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NOS3—intracranial aneurysm	0.00228	0.00248	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTSS—intracranial aneurysm	0.00218	0.00238	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTSK—intracranial aneurysm	0.00201	0.00219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00188	0.00205	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AGER—intracranial aneurysm	0.00187	0.00204	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NCF1—intracranial aneurysm	0.00186	0.00203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AGER—intracranial aneurysm	0.00184	0.00201	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP9—intracranial aneurysm	0.00176	0.00193	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EDNRA—intracranial aneurysm	0.00176	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CST3—intracranial aneurysm	0.00175	0.00191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00171	0.00186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTSB—intracranial aneurysm	0.00166	0.00181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NCF1—intracranial aneurysm	0.00165	0.0018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NCF1—intracranial aneurysm	0.00153	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCL2—intracranial aneurysm	0.00147	0.0016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS3—intracranial aneurysm	0.00131	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS3—intracranial aneurysm	0.0011	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AGER—intracranial aneurysm	0.00107	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NCF1—intracranial aneurysm	0.00107	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EDNRA—intracranial aneurysm	0.00101	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL2—intracranial aneurysm	0.000866	0.000944	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL2—intracranial aneurysm	0.000842	0.000918	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOS3—intracranial aneurysm	0.000772	0.000842	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS3—intracranial aneurysm	0.000633	0.00069	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—intracranial aneurysm	0.000619	0.000675	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NOS3—intracranial aneurysm	0.00053	0.000578	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL2—intracranial aneurysm	0.000497	0.000542	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOS3—intracranial aneurysm	0.000443	0.000483	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—intracranial aneurysm	0.000356	0.000388	CbGpPWpGaD
